GNMX
Aevi Genomic Medicine Inc
GNMX
GNMX
Delisted
GNMX was delisted on the 3rd of February, 2020.
44 hedge funds and large institutions have $15.6M invested in Aevi Genomic Medicine Inc in 2018 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 12 increasing their positions, 7 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
Holders
44
Holding in Top 10
1
Calls
$70K
Puts
–
Top Buyers
| 1 | +$275K | |
| 2 | +$74.1K | |
| 3 | +$38.6K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$21K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$19.9K |
Top Sellers
| 1 | -$307K | |
| 2 | -$129K | |
| 3 | -$103K | |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$21K |
| 5 |
TD Asset Management
Toronto,
Ontario, Canada
|
-$14K |